Insulet (PODD) Position Has Boosted by Kames Capital Plc; Moors & Cabot Upped Its Jpmorgan Chase & Co (JPM) Holding

May 23, 2018 - By Ash

Insulet Corporation (NASDAQ:PODD) Logo

Moors & Cabot Inc increased its stake in Jpmorgan Chase & Co (JPM) by 4.12% based on its latest 2017Q4 regulatory filing with the SEC. Moors & Cabot Inc bought 3,324 shares as the company’s stock rose 0.67% while stock markets declined. The institutional investor held 83,991 shares of the major banks company at the end of 2017Q4, valued at $8.96M, up from 80,667 at the end of the previous reported quarter. Moors & Cabot Inc who had been investing in Jpmorgan Chase & Co for a number of months, seems to be bullish on the $380.60 billion market cap company. The stock decreased 1.07% or $1.21 during the last trading session, reaching $111.8. About 5.36M shares traded. JPMorgan Chase & Co. (NYSE:JPM) has risen 23.99% since May 23, 2017 and is uptrending. It has outperformed by 12.44% the S&P500.

Kames Capital Plc increased its stake in Insulet Corporation (PODD) by 212.13% based on its latest 2017Q4 regulatory filing with the SEC. Kames Capital Plc bought 161,290 shares as the company’s stock rose 25.88% while stock markets declined. The institutional investor held 237,324 shares of the medical and dental instruments company at the end of 2017Q4, valued at $16.38 million, up from 76,034 at the end of the previous reported quarter. Kames Capital Plc who had been investing in Insulet Corporation for a number of months, seems to be bullish on the $5.19B market cap company. The stock increased 1.03% or $0.9 during the last trading session, reaching $88.39. About 67,992 shares traded. Insulet Corporation (NASDAQ:PODD) has risen 105.60% since May 23, 2017 and is uptrending. It has outperformed by 94.05% the S&P500.

Since January 13, 2018, it had 3 insider buys, and 8 insider sales for $18.63 million activity. Another trade for 3,783 shares valued at $425,399 was made by Giles Nicole on Saturday, January 13. Friedman Stacey sold $1.99 million worth of JPMorgan Chase & Co. (NYSE:JPM) on Saturday, January 13. $2.00 million worth of JPMorgan Chase & Co. (NYSE:JPM) was bought by HOBSON MELLODY L. BACON ASHLEY had sold 16,434 shares worth $1.84 million. $1.49M worth of JPMorgan Chase & Co. (NYSE:JPM) was bought by Combs Todd A. on Monday, May 14. 7,280 shares were bought by CROWN JAMES S, worth $825,327.

More notable recent JPMorgan Chase & Co. (NYSE:JPM) news were published by: Seekingalpha.com which released: “JPMorgan back to business in China” on May 14, 2018, also Benzinga.com with their article: “Benzinga’s Insider Buys Of The Week: JPMorgan, Philip Morris And More” published on May 20, 2018, Investorplace.com published: “5 Top Stock Trades for Wednesday Morning” on May 22, 2018. More interesting news about JPMorgan Chase & Co. (NYSE:JPM) were released by: Seekingalpha.com and their article: “JPMorgan Chase: A Compelling Upside Case” published on May 03, 2018 as well as Seekingalpha.com‘s news article titled: “JPMorgan: Magnificent Morgan” with publication date: April 30, 2018.

Moors & Cabot Inc, which manages about $754.95M US Long portfolio, decreased its stake in Cardinal Health Inc (NYSE:CAH) by 10,736 shares to 5,181 shares, valued at $315,000 in 2017Q4, according to the filing. It also reduced its holding in Spdr Gold Trust (GLD) by 2,492 shares in the quarter, leaving it with 27,932 shares, and cut its stake in Cvs Health Corp (NYSE:CVS).

Among 34 analysts covering JPMorgan Chase & Co (NYSE:JPM), 18 have Buy rating, 2 Sell and 14 Hold. Therefore 53% are positive. JPMorgan Chase & Co had 120 analyst reports since July 21, 2015 according to SRatingsIntel. On Wednesday, January 17 the stock rating was maintained by Wells Fargo with “Buy”. On Friday, April 28 the stock rating was maintained by Vining Sparks with “Outperform”. As per Thursday, October 6, the company rating was downgraded by Sandler O’Neill. As per Wednesday, August 12, the company rating was maintained by Deutsche Bank. The stock has “Buy” rating by UBS on Friday, February 5. Argus Research maintained JPMorgan Chase & Co. (NYSE:JPM) rating on Friday, January 15. Argus Research has “Buy” rating and $70.0 target. Deutsche Bank downgraded JPMorgan Chase & Co. (NYSE:JPM) on Tuesday, September 26 to “Hold” rating. BMO Capital Markets upgraded the stock to “Outperform” rating in Wednesday, September 16 report. The company was maintained on Monday, March 19 by Credit Suisse. RBC Capital Markets maintained the shares of JPM in report on Tuesday, September 26 with “Buy” rating.

Investors sentiment decreased to 0.88 in Q4 2017. Its down 0.03, from 0.91 in 2017Q3. It fall, as 55 investors sold JPM shares while 802 reduced holdings. 142 funds opened positions while 611 raised stakes. 2.46 billion shares or 1.60% less from 2.50 billion shares in 2017Q3 were reported. Nwq Invest Management Limited Liability Company holds 1.83% of its portfolio in JPMorgan Chase & Co. (NYSE:JPM) for 1.32 million shares. Jaffetilchin Investment Ptnrs Limited Liability Corp reported 4,149 shares or 0.15% of all its holdings. Lafleur And Godfrey Limited Liability Company owns 128,666 shares or 3.38% of their US portfolio. 14,962 are owned by Gm Advisory Group. Portfolio Solutions Ltd Liability has 103 shares. Schwerin Boyle Capital Mngmt holds 2.92% or 250,195 shares in its portfolio. Osborne Ptnrs Capital Management Limited Liability reported 223,649 shares stake. 830,147 were accumulated by Artemis Inv Mngmt Limited Liability Partnership. The California-based Kelly Lawrence W & Assocs Ca has invested 1.19% in JPMorgan Chase & Co. (NYSE:JPM). Sun Life Financial stated it has 0.08% of its portfolio in JPMorgan Chase & Co. (NYSE:JPM). Moreover, Franklin Street Advsrs Nc has 2.6% invested in JPMorgan Chase & Co. (NYSE:JPM) for 162,305 shares. Guardian Capital Ltd Partnership owns 240,081 shares or 0.38% of their US portfolio. Tru Of Toledo Na Oh holds 1.66% of its portfolio in JPMorgan Chase & Co. (NYSE:JPM) for 62,407 shares. 117,799 were reported by Dsc Advsr Limited Partnership. Rmsincerbeaux Capital Limited Company has 39,564 shares for 3.86% of their portfolio.

Among 21 analysts covering Insulet Corporation (NASDAQ:PODD), 15 have Buy rating, 1 Sell and 5 Hold. Therefore 71% are positive. Insulet Corporation had 58 analyst reports since July 29, 2015 according to SRatingsIntel. The stock of Insulet Corporation (NASDAQ:PODD) earned “Buy” rating by Canaccord Genuity on Thursday, January 4. Canaccord Genuity maintained it with “Buy” rating and $90.0 target in Tuesday, March 13 report. Robert W. Baird maintained the shares of PODD in report on Thursday, September 7 with “Buy” rating. The firm earned “Buy” rating on Wednesday, March 28 by Cowen & Co. The firm has “Equal-Weight” rating by Stephens given on Thursday, February 22. Barclays Capital maintained the stock with “Overweight” rating in Thursday, February 22 report. The firm earned “Hold” rating on Thursday, August 13 by Benchmark. The company was maintained on Friday, October 13 by Robert W. Baird. Morgan Stanley maintained the shares of PODD in report on Friday, November 3 with “Equal-Weight” rating. The stock of Insulet Corporation (NASDAQ:PODD) has “Buy” rating given on Thursday, October 5 by Piper Jaffray.

Kames Capital Plc, which manages about $3.95B US Long portfolio, decreased its stake in Calatlantic Group Inc. by 293,952 shares to 14,168 shares, valued at $799,000 in 2017Q4, according to the filing. It also reduced its holding in The Clorox Company (NYSE:CLX) by 304,107 shares in the quarter, leaving it with 147,592 shares, and cut its stake in Apple Inc. (NASDAQ:AAPL).

JPMorgan Chase & Co. (NYSE:JPM) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Ash

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: